"CHI Saint Joseph Health - Saint Joseph London is dedicated to delivering high quality, compassionate care to London and nearby communities. Visit us at 1001 Saint Joseph Drive or call (606) 330-6000 for more information."

During the past decade, Saint Joseph London conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 18 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 18 clinical trials were completed. i.e. 32.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph London" #1 sponsor was "National Cancer Institute (NCI)" with 57 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored and "Wake Forest University Health Sciences" with 15 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph London" #1 collaborator was "National Cancer Institute (NCI)" with 65 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph London" are "Invasive Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IIIB Lung Cancer AJCC v8" (5 trials), "Unresectable Melanoma" (5 trials) and "Clinical Stage IV Cutaneous Melanoma AJCC v8" (4 trials). Many other conditions were trialed in "Saint Joseph London" in a lesser frequency.

Most popular intervention types in "Saint Joseph London" are "Drug" (93 trials), "Other" (67 trials), "Biological" (54 trials), "Procedure" (40 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (32 trials), "Computed Tomography" (26 trials), "Questionnaire Administration" (26 trials), "Biospecimen Collection" (25 trials) and "Laboratory Biomarker Analysis" (24 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph London" are 108 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph London". undefined are not yet recruiting, 55 are recruiting, 57 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Saint Joseph London, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph London, 3 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Saint Joseph London has several departments that took part in Clinical trials: "Saint Joseph Radiation Oncology Resource Center" - 171 trials